MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
ConditionObsessive-Compulsive Disorder
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorCarolyn Rodriguez
About this trial
The study assesses the safety and preliminary effectiveness of MDMA-assisted cognitive behavioral therapy in participants diagnosed with obsessive-compulsive disorder (OCD).
Eligibility criteria
Qualifiers
At least 18 years old
Fluent in speaking and reading the predominantly used or recognized language of the study site
Able to swallow pills
Meet the criteria for OCD diagnosis
Disqualifiers
Pregnant or nursing, or able to become pregnant and are not practicing an effective means of birth control
Weigh less than 48 kilograms (kgs)
Any current problem which, in the opinion of the investigator or study physician, might interfere with participation
Trial design
Treatments tested in this trial
- 3,4-Methyl enedioxy methamphetamine
- Methamphetamine
- Cognitive Behavioral Therapy (CBT)
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Carolyn Rodriguez
Lead sponsor
Stanford University
Sponsor institution
Source ClinicalTrials.gov